Pharmacy Times

JULY 12, 2025

At McKesson ideaShare 2025, pharmacy leaders spotlighted the growing role of pharmacists in expanding clinical services, including telehealth, contraception prescribing, naloxone access, and point-of-care testing (POCT). SHOW MORE Pharmacy-based clinical services demonstrate both public health impact and financial sustainability.

65

65

PharmaVoice

JULY 8, 2025

Published July 8, 2025 Michael Gibney Senior Editor & Writer post share post print email license Getty Images via Getty Images Listen to the article 4 min This audio is auto-generated. Following years of relatively unsubstantial M&A in the biopharma industry, will 2025 be a long-awaited turning point?

Insurance 130

Insurance Packaging Immunization 130

The Checkup by Singlecare

APRIL 29, 2025

The ophthalmic solution has an immune-suppressing active ingredient, cyclosporine. How much does Cequa cost without insurance? The exact cost of Cequa without health insurance will vary, depending on which pharmacy is used. The listed price without insurance references the price of brand-name drugs (unless otherwise specified).

Insurance 52

Insurance Insurance Coverage Immunization 52

Drug Topics

JULY 1, 2025

They look at the list and they prioritize who they want to take on and who they don't want to take on based on their insurance plan and their drugs. That's dependent upon their insurance plan and the medications they use. That means a robust immunization program for COVID-19, flu, shingles, pneumococcal and beyond.

Health and Personal Care Stores 544

Health and Personal Care Stores Independent Pharmacies Grocery Stores Insurance 544

Drug Topics

JUNE 25, 2025

Investigators find that current practices among pharmacists are not fully in alignment with American Diabetes Association (ADA) guideline recommendations for glucagon use, with frequently identified barriers including cost, patient health literacy, and insurance coverage. of patients on a short-acting insulin and 2.3%

Insurance Coverage 380

Insurance Coverage Insurance Compounding Prescription Filling 380

Drug Topics

JUNE 25, 2025

Aside from disparities in HbA1c and overall CGM use, researchers uncovered inequities in CGM wear time and access, according to an abstract presented at the American Diabetes Association’s 85th Scientific Sessions, held in Chicago, Illinois, from June 20-23, 2025. Among those with T1D, at least 40% are using CGMs.

Insurance Coverage 346

Insurance Coverage Insurance Compounding Specialty Pharmacies 346

PharmTech

JUNE 10, 2025

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. On June 9, 2025, Secretary of Health and Human Services Robert F. Kennedy Jr.

Vaccines 85

Vaccines Dosage Packaging Immunization 85

Pharmaceutical Technology

JUNE 13, 2025

June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. The technology utilises outer membrane vesicles (OMVs) to deliver antigens, often eliminating the need for adjuvants while triggering the immune response. Give your business an edge with our leading industry insights.

Vaccines 87

Vaccines Communication Hospitals Packaging 87

Drug Topics

JUNE 26, 2025

Mifepristone Reduces HbA1c in Patients With T2D, Hypercortisolism | ADA 2025 / Carl - stock.adobe.com Data from CATALYST ( NCT05772169 ) showed that mifepristone met its primary endpoint of reduction in HbA1c compared to placebo at 24 weeks. Accessed June 26, 2025. June 23, 2025. Accessed June 26, 2025. May 30, 2025.

Compounding 315

Compounding Specialty Pharmacies Independent Pharmacies Insurance 315

Drug Topics

JUNE 25, 2025

1 GLP-1 Use Increased Significantly Among Pediatric Patients With T2D in Past 5 Years | ADA 2025 / Edugrafo - stock.adobe.com In recent years, type 2 diabetes has become increasingly common among adolescents in the United States.

Compounding 363

Compounding Specialty Pharmacies Independent Pharmacies Insurance 363

Pharmaceutical Technology

JUNE 6, 2025

June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will support clinical milestones along with AI-driven development across Juvenescence’s portfolio. The acquisition forms a key part of Juvenescence’s partnership with the Abu Dhabi global healthcare company M42, which was announced in April 2025.

Communication 52

Communication Hospitals Packaging Compounding 52

Pharmaceutical Technology

JUNE 12, 2025

Robert Barrie June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The pact is a significant moment for Novo Nordisk, pouring significant resources into research that is not centred around incretins. Struggles at the drugmaker culminated in long-time CEO Lars Fruergaard Jørgensen stepping down in May 2025.

Compounding 59

Compounding Communication Hospitals Packaging 59

Pharmaceutical Technology

JULY 14, 2025

Robert Barrie July 14, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Broader label coverages for Pfizer and Moderna’s vaccines mean they have made in-roads into GSK’s RSV dominant market share. FDA approvals do not automatically mean shots enter national immunisation schedules. Login Registration is disabled.

52

52

Pharmaceutical Technology

JUNE 23, 2025

June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook argenx is collaborating with regional regulatory authorities to facilitate patient access to the treatment. Credit: Wirestock Creators/Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.

Communication 52

Communication Hospitals Packaging Insurance 52

Drug Topics

JUNE 24, 2025

Obesity-related mortality continued to rise following the COVID-19 pandemic, despite rates expected to stabilize during this time, according to an abstract presented at the American Diabetes Association’s 85th Scientific Sessions, held in Chicago, Illinois, from June 20-23, 2025. Accessed June 24, 2025. With at least 2.8 2022.780872.

Compounding 505

Compounding Specialty Pharmacies Independent Pharmacies Insurance 505

Pharmaceutical Technology

JUNE 23, 2025

June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HBM7020 activates immune system T cells to target and destroy B cells and plasma cells involved in many autoimmune diseases. Credit: luchschenF /Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JUNE 12, 2025

June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company leverages machine learning and AI to detect microbial proteins that mimic certain cancer antigens. Recently, Enterome announced its plan to present new data at the International Conference on Malignant Lymphoma (ICML) in Lugano on 21 June 2025.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JUNE 25, 2025

GlobalData Healthcare June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Changes to ACIP could result in regulatory uncertainty for vaccine developers and manufacturers. Credit: Melnikov Dimitriy via Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.

Vaccines 52

Vaccines Packaging Hospitals Communication 52

Pharmacy Times

JUNE 23, 2025

Goldman and Isaacs emphasize the importance of identifying at-risk patients through various health care touchpoints, including doctor's offices and pharmacies, and advocate for routine glucagon prescription and insurance coverage. But I also think everyone should have a ready-to-use cover on their insurance.

Compounding Pharmacies 73

Compounding Pharmacies Insurance Immunization Insurance Coverage 73

Drug Topics

JUNE 23, 2025

Successful RCM implementation can help pharmacies recover significant funds, with Outcomes reporting nearly $3 million recovered for clients in 2024 and 2025.

Patient Care 247

Patient Care Vaccines Specialty Pharmacies Compounding 247

Pharmacy Times

JUNE 17, 2025

That means that pharmacists in the twilight of their career have, at some point, filled a prescription, engaged in drug utilization review, filed insurance claims, and counseled per the Omnibus Budget Reconciliation Act of 1990 regulations for many of the products now found in front of the counter. Accessed May 5, 2025. November 2022.

Compounding Pharmacies 132

Compounding Pharmacies Drug Utilization Review Immunization Compounding 132

Pharmacy Times

JUNE 22, 2025

They highlighted that only 4% of the 15 million people using insulin have a glucagon prescription, largely due to misconceptions about ease of use, cost, and insurance coverage. My insurance isn't going to cover it, and so people don't even try to prescribe it.

Compounding Pharmacies 65

Compounding Pharmacies Immunization Insurance Coverage Specialty Pharmacies 65

Pharmacy Times

JUNE 23, 2025

Sayer primarily focuses on barriers to insurance coverage and the need for educational efforts among health care providers and patients. People want products reimbursed, and they're much more likely to use a product if it's paid for by the insurance system. That'll all be fully implemented by the end of 2025.

Insurance Coverage 65

Insurance Coverage Compounding Pharmacies Compounding Insurance 65

Drug Topics

JUNE 25, 2025

Leveraging Washington State's progressive pharmacist scope, which allows direct billing to Medicaid and commercial insurances, the program demonstrated the potential of integrating clinical pharmacists into primary care settings.

Insurance Coverage 247

Insurance Coverage Insurance Vaccines Specialty Pharmacies 247

Drug Topics

JULY 5, 2025

Kevin Cleveland, PharmD, professor at Idaho State University, explores the potential impacts of changes to the Advisory Committee on Immunization Practices (ACIP), highlighting concerns about shifting medical guidance and vaccine recommendations. Kevin Cleveland, PharmD: It's going to be pretty significant.

Patient Care 247

Patient Care Vaccines Insurance Immunization 247

Pharmacy Times

JULY 3, 2025

Getting this passed would mean broadening coverage within CMS, and then, hopefully, private insurers would follow suit. CMS leads the way when it comes to new therapies and approval, so hopefully, this means broadening access to both private and government-based insurers.

Compounding Pharmacies 81

Compounding Pharmacies FDA Immunization Packaging 81

Pharmacy Times

JULY 1, 2025

Utilization of HER2 therapies is positively associated with private insurance, academic facility treatment, and recent diagnosis years. Disparities in HER2 therapy access are linked to rural treatment, Black race, Medicare insurance, and older age. 3 Among the patients, approximately 75.8% in 2013 to 80.9%

Compounding Pharmacies 100

Compounding Pharmacies Insurance Vaccines Immunization 100

Pharmacy Times

JUNE 30, 2025

June 30, 2025) – The National Community Pharmacists Association today issued a statement on behalf of CEO B. PCMA unanimous Supreme Court decision in 2020, which allowed states to regulate PBMs, the big health insurance companies and their PBM lobby have been barnstorming the country putting up one legal challenge after another.

Community Pharmacies 65

Community Pharmacies Compounding Pharmacies Immunization Health Insurance Companies 65

Pharmacy Times

JULY 4, 2025

Patients with inflammatory conditions achieved similar clinical outcomes after switching from the reference adalimumab (Humira; AbbVie) to a biosimilar, according to real-world data presented at the 2025 American Society of Health-System Pharmacists Pharmacy Futures Meeting.

Specialty Pharmacies 86

Specialty Pharmacies Hospitals Compounding Pharmacies Vaccines 86

Pharmaceutical Technology

JULY 8, 2025

July 8, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The collaboration will leverage Chugai’s antibody engineering technologies to create new drug candidates. Go deeper with GlobalData Reports LOA and PTSR Model - Briquilimab in Severe Combined Immune Deficien. Sign up for our daily news round-up!

Packaging 52

Packaging Immunization Hospitals Communication 52

Pharmacy Times

JULY 1, 2025

You also look at sometimes the unfortunate situation of the patient's insurance, for example, no longer covering the medication, whether it's an insurance formulary change or, for example, a patient switches insurances due to a job change. We on our own help to navigate patients through that process as well.

Specialty Pharmacies 65

Specialty Pharmacies Insurance Compounding Pharmacies Hospitals 65

Pharmaceutical Technology

JUNE 16, 2025

GlobalData Healthcare June 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Surovatamig’s global sales are projected to reach $138 million by 2031. GlobalData Healthcare June 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Surovatamig’s global sales are projected to reach $138 million by 2031.

Labelling 52

Labelling Communication Hospitals Vaccines 52

Pharmaceutical Technology

JUNE 20, 2025

June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The treatments can be accessed through facilities such as Royal Prince Alfred Hospital, Westmead Hospital and the Sydney Children’s Hospitals Network. Data Insights The gold standard of business intelligence. Don’t let policy changes catch you off guard.

Hospitals 52

Hospitals Communication Immunization Packaging 52

Pharmaceutical Technology

JULY 1, 2025

July 1, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The therapy can be administered either intravenously or subcutaneously. Credit: HenadziPechan/Shutterstock. Stay proactive with real-time data and expert analysis. Give your business an edge with our leading industry insights. Login Registration is disabled.

FDA 52

FDA Packaging Communication Hospitals 52

Pharmaceutical Technology

JULY 4, 2025

July 4, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook BRII-693 is a potential solution for patients with multidrug-resistant and extensively drug-resistant gram-negative bacterial infections. Go deeper with GlobalData Reports LOA and PTSR Model - Briquilimab in Severe Combined Immune Deficien.

Hospitals 52

Hospitals Packaging Communication Immunization 52

Pharmaceutical Technology

JUNE 11, 2025

Robert Barrie June 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Gilead said it is “committed to working with regulatory authorities to resolve the issues underlying the clinical hold” Credit: Melnikov Dmitriy via Shutterstock. CD4+T-cells and lymphocytes are both crucial elements of the immune system.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents FDA Communication Hospitals 52

Pharmaceutical Technology

JULY 3, 2025

Robert Barrie July 3, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Regeneron’s drug joins two fellow BCMAxCD3 bispecific antibodies already at market in the US. Credit: lev radin via Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.

FDA 52

FDA Packaging Communication Hospitals 52